A partner of choice

Helsinn

Scroll to discover

Scroll to discover

Helsinn About Us

We are a global pharmaceutical company and a leader in supportive care focused on improving the health and quality of life of patients with cancer and chronic diseases.

Learn more

We have always been driven by the desire to improve the lives of cancer patients, guided by core values of integrity, passion and quality.

Learn more
Technology

A Comprehensive Technical Organization

Our technical organization orchestrates a balanced mix of internal and external capabilities, covering multiple aspect from development and regulatory affairs, to manufacturing and supply chain.
Beyond routine production at our state-of-the-art manufacturing plant in Ireland, we thrive in new product development starting from deep internal know-how and extensive cross-functional collaborations, seamlessly transforming strategic thoughts into real brands and evolutions thereof.

Learn more
Business

The partner of choice

We build, launch and commercialize solid brands globally with a strong focus in supportive care, able to reach patients worldwide through our extensive commercial and supply network, leveraging our integrated platform based on broad technical expertise.

Learn more
ESG

Committed to responsible business growth

We believe building the trust of stakeholders through maximizing positive societal impact will, in turn, make Helsinn more sustainable. Prioritizing the well-being of patients and society creates a virtuous cycle, strengthening our reputation, fostering collaboration, and driving innovation.

Sustainability

Over the years, Helsinn has remained committed to running a responsible and sustainable business by delivering high quality products to patients, whilst reducing and improving our impact on the environment and society. Sustainability has always been one of the main drivers in our corporate culture and has become a crucial element of our strategic vision.

Learn more

Carbon Neutral Company

For the third year we have achieved carbon neutrality. We have progressed on our path towards a reduction of our greenhouse gas footprint and the remaining emissions have been offset through the purchase of Gold Standard certificates.

Learn more

Ethics and Governance

We always strive to go further and bring better todays to even more and more patients. Our ethical reputation are the key ingredients to deliver this ambitious promise to patients and gain their trust. It is therefore vital that we hold ourselves to the highest ethical standards across our entire business, above and beyond what is required.

Corporate Governance
Our News

Read our news and insights

Featured News
12/06/24

Helsinn Group and Chugai Pharma Europe sign a partnership agreement renewal to commercialize AKYNZEO® in the UK and Ireland

Learn more
Featured News
12/06/24

Helsinn Group and Chugai Pharma Europe sign a partnership agreement renewal to commercialize AKYNZEO® in the UK and Ireland

Learn more

Partnership with Immedica for commercialisation of cancer supportive car

Helsinn and Immedica enter exclusive partnership for commercialisation of cancer supportive care products in core European markets

Learn more

Helsinn closes financing agreement with Oberland Capital

Helsinn Group, a fully integrated, global biopharma company with a track record of over forty years of commercial execution and a strong focus in oncology and rare diseases announced a financing agreement with Oberland Capital Management LLC

Learn more

Dr. Melanie Rolli - Group Chief Executive Officer

Helsinn Group announced the appointment of the Group’s current Chief Operating Officer, Dr Melanie Rolli as Group Chief Executive Officer (“CEO”) effective from January 1st, 2023.

Learn more

Phase 3 trial in patients with CINV

Helsinn Group announced results from a secondary analysis of the Phase 3 multicenter pivotal trial in patients with breakthrough chemotherapy-induced nausea and vomiting (CINV) receiving antiemetic prophylaxis (oral or IV NEPA)

Learn more